Navigating Complex Biologics to Clinic Faster

Overview


Catalent-I-Pharma-2016-Navigating-Complex-Biologics-to-Clinic-Faster.png

With the increasing complexity of biologics and growing competition with players ranging from small start-ups to large pharma, an aggressive development timeline is required to bring your biologic drug to clinic faster. A comprehensive approach involving advanced drug delivery and development technologies, as well as cutting-edge analytical techniques, can create a tailored solution to support your development goals.  Click to download your solution to bring your biologics to clinic faster

This content is provided by Catalent, and any views and opinions expressed do not necessarily reflect those of Biopharma-Reporter.com

Download Now


Related Resources

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent

Product Brochure

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring an existing manufacturing process.

Considerations for Process Characterization of Biologics

Considerations for Process Characterization of Biologics

Content provided by Catalent

Insight Guide

Process characterization is an important step in the product development journey. Download this Q&A article to learn the latest trends, status, and insights into process characterization and validation of monoclonal antibodies and recombinant proteins.

Supplier Info Centre

Catalent.jpg

For more product information visit Catalent.